Ovid Therapeutics (OVID) Q3 2024 Earnings

13AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.22
-0.11
0.01
0.12

Details

Expected EPS
-0.223919
Actual EPS
0.12
Surprise EPS
0.34
Surprise Percent
+153.59%

Description

Ovid Therapeutics (OVID) has reported earnings of 0.12 per share for Q3 2024.

0 Comments

Share your thoughts